Torrent Pharma sees share price jump on strong Q2 performance
pre-market1 source ↓written by the desknot a recommendation
- for Q2 FY26
- 14.3% Y-o-Y revenue increase
- to ₹3
- 6.65%
- market growth
- 8%
- in India business
- 11.5% growth
- Volume contribution
- 3.7%
Torrent Pharmaceuticals reported a 14.3% Y-o-Y revenue increase for Q2 FY26, driven by strong growth in high-demand therapeutic segments. The stock surged 6.65% to ₹3,817 following positive broker upgrades, reflecting enhanced earnings expectations for FY27. The company's robust performance in cardiac and gastrointestinal therapies outpaced the overall Indian pharma market growth of 8%. 📈
• 11.5% growth in India business
• Volume contribution: 3.7%
• Price growth: 5.5%
This growth trajectory may bolster investor sentiment in the pharma sector.
Not investment advice. For informational purposes only.